These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation. Takada H; Imoto I; Tsuda H; Nakanishi Y; Ichikura T; Mochizuki H; Mitsufuji S; Hosoda F; Hirohashi S; Ohki M; Inazawa J Oncogene; 2005 Dec; 24(54):8051-60. PubMed ID: 16103878 [TBL] [Abstract][Full Text] [Related]
3. Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer. Kikuchi R; Tsuda H; Kozaki K; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I Cancer Res; 2008 Jul; 68(13):5067-75. PubMed ID: 18593905 [TBL] [Abstract][Full Text] [Related]
4. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer. Takada H; Wakabayashi N; Dohi O; Yasui K; Sakakura C; Mitsufuji S; Taniwaki M; Yoshikawa T Cancer Genet Cytogenet; 2010 Feb; 197(1):16-24. PubMed ID: 20113832 [TBL] [Abstract][Full Text] [Related]
5. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma. Sonoda I; Imoto I; Inoue J; Shibata T; Shimada Y; Chin K; Imamura M; Amagasa T; Gray JW; Hirohashi S; Inazawa J Cancer Res; 2004 Jun; 64(11):3741-7. PubMed ID: 15172977 [TBL] [Abstract][Full Text] [Related]
6. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674 [TBL] [Abstract][Full Text] [Related]
8. PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation. Suzuki E; Imoto I; Pimkhaokham A; Nakagawa T; Kamata N; Kozaki KI; Amagasa T; Inazawa J Oncogene; 2007 Dec; 26(57):7921-32. PubMed ID: 17599052 [TBL] [Abstract][Full Text] [Related]
9. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer. Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676 [TBL] [Abstract][Full Text] [Related]
10. Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas. Wen XZ; Akiyama Y; Baylin SB; Yuasa Y Oncogene; 2006 Apr; 25(18):2666-73. PubMed ID: 16314833 [TBL] [Abstract][Full Text] [Related]
11. Loss of estrogen receptor-alpha expression is associated with hypermethylation near its ATG start codon in gastric cancer cell lines. Woo IS; Park MJ; Choi SW; Kim SJ; Lee MA; Kang JH; Hong YS; Lee KS Oncol Rep; 2004 Mar; 11(3):617-22. PubMed ID: 14767512 [TBL] [Abstract][Full Text] [Related]
12. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer. Wanajo A; Sasaki A; Nagasaki H; Shimada S; Otsubo T; Owaki S; Shimizu Y; Eishi Y; Kojima K; Nakajima Y; Kawano T; Yuasa Y; Akiyama Y Gastroenterology; 2008 Aug; 135(2):580-90. PubMed ID: 18588891 [TBL] [Abstract][Full Text] [Related]
13. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Suzuki H; Yamamoto E; Nojima M; Kai M; Yamano HO; Yoshikawa K; Kimura T; Kudo T; Harada E; Sugai T; Takamaru H; Niinuma T; Maruyama R; Yamamoto H; Tokino T; Imai K; Toyota M; Shinomura Y Carcinogenesis; 2010 Dec; 31(12):2066-73. PubMed ID: 20924086 [TBL] [Abstract][Full Text] [Related]
14. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer. Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792 [TBL] [Abstract][Full Text] [Related]
15. The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration. Kim SK; Jang HR; Kim JH; Noh SM; Song KS; Kim MR; Kim SY; Yeom YI; Kim NS; Yoo HS; Kim YS Biochem Biophys Res Commun; 2006 Oct; 349(3):1032-40. PubMed ID: 16959213 [TBL] [Abstract][Full Text] [Related]
16. Novel regions of chromosomal amplification at 6p21, 5p13, and 12q14 in gastric cancer identified by array comparative genomic hybridization. Gorringe KL; Boussioutas A; Bowtell DD; Genes Chromosomes Cancer; 2005 Mar; 42(3):247-59. PubMed ID: 15611932 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion. Kim M; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Norman JC; Caswell PT; Kang GH; Kim SY; Yoo HS; Kim YS Carcinogenesis; 2008 Mar; 29(3):629-37. PubMed ID: 18283041 [TBL] [Abstract][Full Text] [Related]
19. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis. Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565 [TBL] [Abstract][Full Text] [Related]
20. Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung. Kang JU; Koo SH; Kwon KC; Park JW Int J Oncol; 2010 Aug; 37(2):327-35. PubMed ID: 20596660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]